The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amendment to Terms of Convertible Loan Stock

23 Aug 2012 07:00

RNS Number : 6045K
Sopheon PLC
23 August 2012
 



 

 

FOR IMMEDIATE RELEASE

23 August 2012

 

 

SOPHEON PLC

 

AMENDMENT TO THE TERMS OF CONVERTIBLE LOAN STOCK

 

 

Sopheon plc ("Sopheon" or "the Group") announces that it has reached agreement with the holders of its convertible unsecured loan stock, and certain new investors, to raise an additional £1,150,000.

 

In 2009, the Company issued £850,000 of convertible unsecured loan stock (the "Initial Loan Stock") to a group of investors including key members of the Board and management team, originally maturing on 2 October 2011. Since then, the holders of the Initial Loan Stock have twice agreed to extend the maturity date, most recently to 31 January 2015. The new loan stock (the "Further Loan Stock") will have a start date of 1 October 2012, and will have the same maturity date and conversion price of 5.0p per share as the Initial Loan Stock. This is equal to yesterday's closing mid-market price, and is above the average closing mid-market price for the last month which was 4.8p per share.

 

As detailed in this morning's interim results announcement for the six months ended 30 June 2012, the Group has been advised that a change in ownership of BlueCrest Capital Finance may lead to uncertainty over future renewals of the group's $1.25m revolving credit facility. The funds raised through the issue of Further Loan Stock will be used to mitigate this risk, and to underpin the Group's expansion strategy.

 

As set out below, of the total investment in Further Loan Stock of £1,150,000, members of the Board and management or their families are subscribing for £665,000.

 

Loan Stock

Initial

Further

Total

Name

£'000

£'000

£'000

Barry Mence, Chairman

200

440

640

Stuart Silcock, Non-Executive Director

100

100

200

Bernard Al, Non-Executive Director

40

20

60

Andrew Michuda, Chief Executive Officer

20

25

45

Arif Karimjee, Chief Financial Officer

12

15

27

Other members of Sopheon Management

43

65

98

External Investors

435

485

930

Total

850

1,150

2,000

 

Of the £485,000 of Further Loan Stock being subscribed by external investors, £440,000 is being subscribed by Norman Nominees Limited, an existing Significant Shareholder that also owns £200,000 of Initial Loan Stock.

 

In accordance with the AIM Rules for Companies, Daniel Metzger, having consulted with the Company's Nominated Adviser, FinnCap, has acted as independent director with respect to this transaction and considers that the amendment to the terms of the convertible loan stock are fair and reasonable insofar as the Company's shareholders are concerned.

 

Chairman Barry Mence said:

 

"I am delighted that the holders of our loan stock have again demonstrated their confidence in Sopheon by committing additional funds in this instrument, and also that we have been able to attract new participants."

 

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

+ 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

+ 44 (0) 1483 685 735

Charlotte Stranner / Henrik Persson / Victoria Bates

finnCap

+ 44 (0) 20 7600 1658

Guy McDougall / Heather Armstrong

Newgate Threadneedle

+ 44 (0) 20 7653 9842

Claire Verhagen

Citigate First Financial

+ 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) is an international provider of software and services. Sopheon's solutions structure, align and manage innovation processes to help organizations generate more revenues and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BASF, Corning, Electrolux, Honeywell, Lockheed Martin, Philips and SABMiller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com. 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVLLFLLVFBBBL
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.